biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Sad But Looks Nice!

<< Previous

Bullboard Posts

Next >>

Comment by prophetoffactzon Jun 23, 2023 6:14pm

236 Views

Post# 35512243

RE:Sad But Looks Nice!

And Russia is in turmoil.

Will Putin fall and cause a rally in risk assets next week and help and last chance BTI may have?

BREAKING: The news coming out of Russia that Yevgeny Prigozhin’s Wagner PMC is waging battle against Putin’s military forces is absolutely INSANE. Developments are happening faster than they can be reported.

<< Previous

Bullboard Posts

Next >>

Investor’s corner: Solving chronic pain in dogs – A significant market opportunity